Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 48

1.

A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia.

Awan FT, Hillmen P, Hellmann A, Robak T, Hughes SG, Trone D, Shannon M, Flinn IW, Byrd JC; LUCID trial investigators.

Br J Haematol. 2014 Nov;167(4):466-77. doi: 10.1111/bjh.13061. Epub 2014 Aug 8.

2.

Limited clinical relevance of imaging techniques in the follow-up of patients with advanced chronic lymphocytic leukemia: results of a meta-analysis.

Eichhorst BF, Fischer K, Fink AM, Elter T, Wendtner CM, Goede V, Bergmann M, Stilgenbauer S, Hopfinger G, Ritgen M, Bahlo J, Busch R, Hallek M; German CLL Study Group (GCLLSG).

Blood. 2011 Feb 10;117(6):1817-21. doi: 10.1182/blood-2010-04-282228. Epub 2010 Dec 7.

3.

High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia.

Heintel D, Kienle D, Shehata M, Kröber A, Kroemer E, Schwarzinger I, Mitteregger D, Le T, Gleiss A, Mannhalter C, Chott A, Schwarzmeier J, Fonatsch C, Gaiger A, Döhner H, Stilgenbauer S, Jäger U; CLL Study Group.

Leukemia. 2005 Jul;19(7):1216-23.

PMID:
15858619
4.

Exploration of anthropological specimens by GC-MS and chemometrics.

Varmuza K, Makristathis A, Schwarzmeier J, Seidler H, Mader RM.

Mass Spectrom Rev. 2005 May-Jun;24(3):427-52. Review.

PMID:
15389850
5.

Splenic mastocytosis: report of two cases and detection of the transforming somatic C-KIT mutation D816V.

Wimazal F, Schwarzmeier J, Sotlar K, Simonitsch I, Sperr WR, Fritsche-Polanz R, Födinger M, Schubert J, Horny HP, Valent P.

Leuk Lymphoma. 2004 Apr;45(4):723-9.

PMID:
15160946
6.

High expression of activation-induced cytidine deaminase (AID) mRNA is associated with unmutated IGVH gene status and unfavourable cytogenetic aberrations in patients with chronic lymphocytic leukaemia.

Heintel D, Kroemer E, Kienle D, Schwarzinger I, Gleiss A, Schwarzmeier J, Marculescu R, Le T, Mannhalter C, Gaiger A, Stilgenbauer S, Döhner H, Fonatsch C, Jäger U; German CLL Study Group.

Leukemia. 2004 Apr;18(4):756-62.

PMID:
14961036
7.

Fatty acid composition and preservation of the Tyrolean Iceman and other mummies.

Makristathis A, Schwarzmeier J, Mader RM, Varmuza K, Simonitsch I, Chavez JC, Platzer W, Unterdorfer H, Scheithauer R, Derevianko A, Seidler H.

J Lipid Res. 2002 Dec;43(12):2056-61.

8.
9.

Association of CD38 antigen expression with other prognostic parameters in early stages of chronic lymphocytic leukemia.

Heintel D, Schwarzinger I, Chizzali-Bonfadin C, Thalhammer R, Schwarzmeier J, Fritzer-Szekeres M, Weltermann A, Simonitsch I, Lechner K, Jaeger U.

Leuk Lymphoma. 2001 Nov-Dec;42(6):1315-21.

PMID:
11911414
10.

Low-dose 2-chlorodeoxyadenosine for the treatment of mycosis fungoides.

Trautinger F, Schwarzmeier J, Hönigsmann H, Knobler RM.

Arch Dermatol. 1999 Oct;135(10):1279-80. No abstract available.

PMID:
10522688
11.

A case of bone marrow mastocytosis associated with multiple myeloma.

Hagen W, Schwarzmeier J, Walchshofer S, Zojer N, Chott A, Sillaber C, Ackermann J, Simonitsch I, Bühring HJ, Drach J, Lechner K, Horny HP, Valent P.

Ann Hematol. 1998 Mar-Apr;76(3-4):167-74.

PMID:
9619735
13.

Non-radioactive detection of the rearranged BCR/ABL sequences amplified by polymerase chain reaction.

Lion T, Prischl F, Haas OA, Pont J, Schwarzmeier J.

Leukemia. 1991 Feb;5(2):156-9.

PMID:
2020197
14.

[The significance of psychosocial complaints in the initial interview--a study of unselected patients of an internal medicine/polyclinic university ambulatory service].

Moser G, Kiss A, Sachs G, Spiess K, Schwarzmeier J.

Psychother Psychosom Med Psychol. 1989 May;39(5):161-7. German.

PMID:
2734431
15.

Beta-2-microglobulin for differentiation between ciclosporin A nephrotoxicity and graft rejection in renal transplant recipients.

Prischl F, Gremmel F, Schwabe M, Schindler J, Balcke P, Kopsa H, Pinter G, Schwarzmeier J, Zazgornik J.

Nephron. 1989;51(3):330-7.

PMID:
2645532
16.

[Efficacy of recombinant interferon alpha-2 in 34 patients with hairy cell leukemia. Effect of splenectomy and dosage reduction results of therapy].

Frey B, Hofmann V, Cavalli F, Fehr J, Kroner T, Nesthus I, Schwarzmeier J.

Schweiz Med Wochenschr. 1988 Oct 15;118(41):1468-75. German.

PMID:
3238389
17.

Role of beta 2-microglobulin in the monitoring of patients after orthotopic heart transplantation.

Prischl F, Teufelsbauer H, Havel M, Laczkovics A, Wolner E, Schwarzmeier J.

Bibl Cardiol. 1988;(43):111-5. No abstract available.

PMID:
3067708
18.

In vitro chemosensitivity testing to predict outcome of therapy in acute leukemia.

Prischl F, Pinter G, Schwarzmeier J.

Chemioterapia. 1987 Jun;6(2 Suppl):679-81. No abstract available.

PMID:
3509520
19.

[Effect of interferon-alpha 2 (E. coli) in hairy cell leukemia].

Hofmann V, Scheel A, Schwarzmeier J, Talstad I, Varini M, Kaplan S, Sauter C, Fehr J.

Schweiz Med Wochenschr. 1985 Feb 16;115(7):235-8. German.

PMID:
3872477
20.

Expression of a myeloid marker on TdT-positive acute lymphocytic leukemic cells: evidence by double-fluorescence staining.

Bettelheim P, Paietta E, Majdic O, Gadner H, Schwarzmeier J, Knapp W.

Blood. 1982 Dec;60(6):1392-6.

Supplemental Content

Loading ...
Support Center